The biotechnology arena’s financing total for 2015 reached unprecedented heights for the second straight year, according to EY’s 29th annual Beyond borders report. Biotech companies raised nearly $71 billion in 2015, well ahead of the previous record of $56 billion totaled during 2014.

A listing of the top 20 pharma/biotech companies ranked by DTC spending in 2015.

Fredrik Wiklund has been made chief operating officer of Bioniz Therapeutics Inc.

The pharma industry’s R&D concentration has been shifting towards specialty therapy areas as research and development returns decline for some leaders.

What are key trends in the transparency compliance landscape?